DCC PLC/ IE0002424939 /
9/20/2024 5:29:53 PM | Chg. -170.00 | Volume | Bid5:30:00 PM | Ask5:30:00 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
5,155.00GBX | -3.19% | 23,475 Turnover(GBP): 1.23 mill. |
-Bid Size: - | -Ask Size: - | 5.1 bill.GBP | - | - |
GlobeNewswire
7/10
Metrc Extends Track-and-Trace Partnership Through New Contract with State of California
GlobeNewswire
3/7
USO brings Dallas Cowboys Cheerleaders on tour to U.S. service members and their families in Korea
GlobeNewswire
2/20
Axsome Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Busines...
GlobeNewswire
11/6/2023
Axsome Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
GlobeNewswire
10/25/2023
Digital Check Corp. Adds Error Detection and Image Cleanup to its SecureLink by Digital Check® Netwo...
GlobeNewswire
10/19/2023
Vislink Amplifies Its Presence in U.S. Broadcast and Video Markets Via Strategic Agreement with AV D...
GlobeNewswire
9/13/2023
The University of St. Augustine for Health Sciences Leads the Charge Toward Effective, Compassionate...
GlobeNewswire
8/28/2023
CPI Aero Receives Second Multi-Year Contract and Funded Order for F-16 Aircraft Structures
GlobeNewswire
3/28/2022
Axsome Therapeutics to Acquire Sunosi® from Jazz Pharmaceuticals, Expanding Axsome’s Leadership in N...
GlobeNewswire
3/8/2022
New AMD Ryzen Threadripper PRO 5000 WX-Series Processors are the Ultimate Workstation Processors for...
GlobeNewswire
3/1/2022
Axsome Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Busines...
GlobeNewswire
2/15/2022
Axsome Therapeutics to Report Fourth Quarter and Full Year 2021 Financial Results on March 1, 2022
GlobeNewswire
11/8/2021
Axsome Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business Update